Academic Journal
Changing treatment patterns for hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results-Medicare study.
| العنوان: | Changing treatment patterns for hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results-Medicare study. |
|---|---|
| المؤلفون: | Iheanacho, Franklin, Tramontano, Angela C, Abrams, Thomas Adam, Manz, Christopher R |
| المصدر: | Cancer ; ISSN:1097-0142 ; Volume:131 ; Issue:1 |
| بيانات النشر: | Wiley |
| سنة النشر: | 2025 |
| المجموعة: | PubMed Central (PMC) |
| مصطلحات موضوعية: | Medicare, Surveillance, Epidemiology, and End Results (SEER) Program, atezolizumab, bevacizumab, hepatocellular carcinoma, sorafenib |
| الوصف: | From 2007 to 2017, sorafenib was the sole systemic therapy for hepatocellular carcinoma (HCC), but nine new therapies were approved from 2017 to 2022. No studies have yet examined population-level treatment patterns for HCC since these approvals. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| Relation: | https://doi.org/10.1002/cncr.35649; https://pubmed.ncbi.nlm.nih.gov/39530255 |
| DOI: | 10.1002/cncr.35649 |
| الاتاحة: | https://doi.org/10.1002/cncr.35649 https://pubmed.ncbi.nlm.nih.gov/39530255 |
| Rights: | © 2024 American Cancer Society. |
| رقم الانضمام: | edsbas.43F210F3 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1002/cncr.35649 |
|---|